Developer docs
API playgroundTry for free, no card

Search company profiles

Teleflex Medical Inc

Full company profile

uuid003fs84

Namestring
Teleflex Medical Inc
Legal namestring
Teleflex Inc
Company typeenum
Public
Founded yearint
1943
Descriptiontext

Teleflex is a publicly traded medical technology company listed on the New York Stock Exchange under ticker TFX and incorporated in Delaware, USA. The company operates as a diversified platform of medical devices spanning eight therapeutic areas: Anesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology, Surgical, Urology, Vascular Access, and Military-Federal applications. Notable products include the Titan SGS Stapler for bariatric sleeve gastrectomy procedures, the IABP Simplicity intra-aortic balloon pump for cardiac support, and the Urolift system for treating benign prostatic hyperplasia. The technology base consists of proprietary medical devices supported by clinical evidence programs, including a 2025 retrospective study for the Titan SGS Stapler.

Teleflex generates revenue through hardware sales of medical devices to enterprise healthcare buyers — primarily hospitals, surgical centers, interventional labs, and military/federal healthcare facilities. Distribution is executed via a direct enterprise field sales force operating globally, complemented by Teleflex Academy, an online clinician education platform that supports product adoption. Pricing is not publicly disclosed and follows a quote-based enterprise sales model typical of regulated medical device procurement.

In 2025, Teleflex completed the acquisition of BIOTRONIK's Vascular Intervention Business, expanding its presence in the cardiovascular device market and signaling continued inorganic growth strategy. The company maintains employer brand strength, recognized by Forbes as one of America's Best Employers for Engineers 2025 and receiving the VETS Indexes Recognized Employer Award for the third consecutive year in 2026.

Short descriptiontext

Teleflex is a publicly traded (NYSE: TFX) medical technology company that designs, manufactures, and sells proprietary medical devices across eight therapeutic areas — including anesthesia, emergency medicine, interventional cardiology/radiology, surgical, urology, and vascular access — to hospitals, surgical centers, and military/federal healthcare facilities worldwide via a direct enterprise sales force.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersMorrisville, United States
HQ citystring
Morrisville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical device manufacturing, vascular access devices, interventional cardiology devices, anesthesia delivery systems, urology medical devices
Industry1 code
1Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
CodeHLAHADAAPrimaryYes
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices
No data
Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Sale of medical devices and healthcare technology solutions across multiple specialty areas including anesthesia, emergency medicine, interventional cardiology/radiology, surgical, urology, and vascular access.

teleflex.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Urolift
Description

A treatment for benign prostatic hyperplasia (BPH) offered by Teleflex's Interventional Urology portfolio.

teleflex.com
Core offering1 text field

Teleflex manufactures and sells proprietary medical devices across multiple specialty areas, including anesthesia delivery and monitoring equipment, emergency medicine devices, interventional cardiology/radiology devices, surgical instruments, urology devices, and vascular access products. The company also offers the Urolift system for benign prostatic hyperplasia (BPH) treatment and supplies medical devices tailored for military and federal healthcare settings. Products are sold primarily to hospitals, surgical centers, emergency departments, and specialty medical practices worldwide.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Teleflex is a diversified medical technology company offering a broad portfolio of medical devices across multiple therapeutic areas. The company operates as a platform of distinct product areas including Anesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Surgical, Urology, and Vascular Access, along with specialized segments for Interventional Urology (Urolift) and Military-Federal applications. Key products include the Titan SGS Stapler for bariatric surgery and the IABP Simplicity system for cardiac support. The portfolio spans from surgical instruments and vascular access devices to interventional cardiology solutions, providing practical medical technology solutions to healthcare professionals.

Product and service10 records
1Anesthesia Medical Devices
CategoryAnesthesia
Description

Medical devices and solutions for anesthesia administration and monitoring used by anesthesiologists and surgical teams in operating rooms and procedural settings.

2Emergency Medicine Devices
CategoryEmergency Medicine
Description

Medical devices and equipment designed for emergency medical care and resuscitation used by EMS providers, emergency departments, and first responders.

3Interventional Cardiology/Radiology Devices
CategoryInterventional Cardiology/Radiology
Description

Minimally invasive devices for cardiovascular and radiologic interventions used by interventional cardiologists and radiologists in cath labs and interventional suites.

4Urolift System
CategoryInterventional Urology
Description

Minimally invasive prostatic urethral lift device for treating benign prostatic hyperplasia (BPH), used by urologists as an alternative to more invasive surgical interventions.

5Military and Federal Medical Devices
CategoryMilitary / Federal Healthcare
Description

Medical devices and solutions configured for military and federal healthcare environments, sold to military treatment facilities and federal medical procurement organizations.

6Surgical Devices and Instruments
CategorySurgical
Description

Surgical instruments and devices including the Titan SGS Stapler, used by general and bariatric surgeons in operating room procedures.

7Urology Devices
CategoryUrology
Description

Medical devices for urological diagnostics and treatment used by urologists in hospitals, ambulatory surgery centers, and specialty practices.

8Vascular Access Devices
CategoryVascular Access
Description

Devices and solutions for vascular access procedures including catheters and related equipment used by clinicians across hospital and outpatient settings.

9Titan SGS Stapler
CategorySurgical Stapling
Description

Surgical stapler designed for sleeve gastrectomy procedures, with retrospective study evidence indicating significantly reduced post-operative GERD rates compared to multi-fire staplers.

10IABP Simplicity
CategoryCardiac Support / Interventional
Description

Intra-aortic balloon pump system providing cardiac support for patients, used by interventional cardiologists and cardiac care teams.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Teleflex completed the acquisition of BIOTRONIK's Vascular Intervention Business in 2025. This strategic acquisition expands Teleflex's presence in the vascular intervention space, adding BIOTRONIK's portfolio of vascular devices to their existing product offerings.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Diversified medical device company with surgical instruments, emergency/critical care, and interventional products that overlap with Teleflex's surgical and emergency medicine portfolios.

TypeBroad incumbent
Description

Global medtech incumbent with overlapping portfolios in interventional cardiology, vascular, surgical, and urology. Comparable as a diversified medical device platform competing with Teleflex across multiple of the same hospital-facing specialties.

TypeDirect peer
Description

Smaller direct competitor focused on general surgery, interventional, and urology devices. Comparable in scale and product mix to Teleflex's surgical and urology franchises.

TypeOthers
Description

Contract manufacturer and supplier of medical device components and finished devices used across interventional and surgical categories. Comparable as an ecosystem participant supporting many of the same hospital-facing device categories as Teleflex.

TypeBroad incumbent
Description

Large medtech incumbent with a strong vascular access, surgical instruments, and anesthesia delivery portfolio that directly overlaps with several of Teleflex's largest product areas.

TypeBroad incumbent
Description

Large medtech division with surgical, interventional, and vascular portfolios that directly overlap with Teleflex's surgical, interventional cardiology/radiology, and vascular access product areas.

TypeEmerging player
Description

Focused cardiovascular device company whose structural heart and critical care products overlap with Teleflex's interventional cardiology portfolio and adjacent cardiac support devices such as the IABP Simplicity.

TypeDirect peer
Description

Mid-cap medtech peer with surgical instruments, neurosurgery, and specialty hospital products. Comparable as a diversified specialty medical device company selling into similar hospital channels as Teleflex.

TypeDirect peer
Description

Directly overlaps with Teleflex in interventional cardiology/radiology, vascular intervention, urology, and surgical devices. Boston Scientific's peripheral intervention and urology franchises compete head-to-head with Teleflex's interventional and Urolift portfolios.

TypeBroad incumbent
Description

Major medtech incumbent with leading interventional cardiology, vascular, and structural heart franchises that compete with Teleflex's interventional cardiology/radiology and BIOTRONIK-acquired vascular intervention business.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Teleflex Medical Inc

Medical Devicesteleflexmedical.com

Teleflex is a publicly traded (NYSE: TFX) medical technology company that designs, manufactures, and sells proprietary medical devices across eight therapeutic areas — including anesthesia, emergency medicine, interventional cardiology/radiology, surgical, urology, and vascular access — to hospitals, surgical centers, and military/federal healthcare facilities worldwide via a direct enterprise sales force.

What Teleflex Medical Inc does

Teleflex is a publicly traded medical technology company listed on the New York Stock Exchange under ticker TFX and incorporated in Delaware, USA. The company operates as a diversified platform of medical devices spanning eight therapeutic areas: Anesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology, Surgical, Urology, Vascular Access, and Military-Federal applications. Notable products include the Titan SGS Stapler for bariatric sleeve gastrectomy procedures, the IABP Simplicity intra-aortic balloon pump for cardiac support, and the Urolift system for treating benign prostatic hyperplasia. The technology base consists of proprietary medical devices supported by clinical evidence programs, including a 2025 retrospective study for the Titan SGS Stapler.

Teleflex generates revenue through hardware sales of medical devices to enterprise healthcare buyers — primarily hospitals, surgical centers, interventional labs, and military/federal healthcare facilities. Distribution is executed via a direct enterprise field sales force operating globally, complemented by Teleflex Academy, an online clinician education platform that supports product adoption. Pricing is not publicly disclosed and follows a quote-based enterprise sales model typical of regulated medical device procurement.

In 2025, Teleflex completed the acquisition of BIOTRONIK's Vascular Intervention Business, expanding its presence in the cardiovascular device market and signaling continued inorganic growth strategy. The company maintains employer brand strength, recognized by Forbes as one of America's Best Employers for Engineers 2025 and receiving the VETS Indexes Recognized Employer Award for the third consecutive year in 2026.

Teleflex Medical Inc firmographics

Firmographics
Name
Teleflex Medical Inc
Legal name
Teleflex Inc
Website
https://teleflexmedical.com
Company type
Public
Founded year
1943
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Teleflex is a publicly traded (NYSE: TFX) medical technology company that designs, manufactures, and sells proprietary medical devices across eight therapeutic areas — including anesthesia, emergency medicine, interventional cardiology/radiology, surgical, urology, and vascular access — to hospitals, surgical centers, and military/federal healthcare facilities worldwide via a direct enterprise sales force.
Ownership category
akta.pro rank

Teleflex Medical Inc industry classification

Industry
Product category
Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

  • Medical device manufacturing
  • Vascular access devices
  • Interventional cardiology devices
  • Anesthesia delivery systems
  • Urology medical devices

Where Teleflex Medical Inc is headquartered

Location

Headquarters

HQ city
Morrisville
HQ country
United States
HQ region
North America

Markets served

Teleflex Medical Inc business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Device Sales: Sale of medical devices and healthcare technology solutions across multiple specialty areas including anesthesia, emergency medicine, interventional cardiology/radiology, surgical, urology, and vascular access.

Distribution channels1 record

Marketing channels1 record

Teleflex Medical Inc product offering

Product offering

Core offering

Teleflex manufactures and sells proprietary medical devices across multiple specialty areas, including anesthesia delivery and monitoring equipment, emergency medicine devices, interventional cardiology/radiology devices, surgical instruments, urology devices, and vascular access products. The company also offers the Urolift system for benign prostatic hyperplasia (BPH) treatment and supplies medical devices tailored for military and federal healthcare settings. Products are sold primarily to hospitals, surgical centers, emergency departments, and specialty medical practices worldwide.

Product overview

Teleflex is a diversified medical technology company offering a broad portfolio of medical devices across multiple therapeutic areas. The company operates as a platform of distinct product areas including Anesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Surgical, Urology, and Vascular Access, along with specialized segments for Interventional Urology (Urolift) and Military-Federal applications. Key products include the Titan SGS Stapler for bariatric surgery and the IABP Simplicity system for cardiac support. The portfolio spans from surgical instruments and vascular access devices to interventional cardiology solutions, providing practical medical technology solutions to healthcare professionals.

Differentiator

Problem solved

Functional benefit

Brands

  • Urolift: A treatment for benign prostatic hyperplasia (BPH) offered by Teleflex's Interventional Urology portfolio.

Products and services

  • Anesthesia Medical Devices Medical devices and solutions for anesthesia administration and monitoring used by anesthesiologists and surgical teams in operating rooms and procedural settings.
  • Emergency Medicine Devices Medical devices and equipment designed for emergency medical care and resuscitation used by EMS providers, emergency departments, and first responders.
  • Interventional Cardiology/Radiology Devices Minimally invasive devices for cardiovascular and radiologic interventions used by interventional cardiologists and radiologists in cath labs and interventional suites.
  • Urolift System Minimally invasive prostatic urethral lift device for treating benign prostatic hyperplasia (BPH), used by urologists as an alternative to more invasive surgical interventions.
  • Military and Federal Medical Devices Medical devices and solutions configured for military and federal healthcare environments, sold to military treatment facilities and federal medical procurement organizations.
  • Surgical Devices and Instruments Surgical instruments and devices including the Titan SGS Stapler, used by general and bariatric surgeons in operating room procedures.
  • Urology Devices Medical devices for urological diagnostics and treatment used by urologists in hospitals, ambulatory surgery centers, and specialty practices.
  • Vascular Access Devices Devices and solutions for vascular access procedures including catheters and related equipment used by clinicians across hospital and outpatient settings.
  • Titan SGS Stapler Surgical stapler designed for sleeve gastrectomy procedures, with retrospective study evidence indicating significantly reduced post-operative GERD rates compared to multi-fire staplers.
  • IABP Simplicity Intra-aortic balloon pump system providing cardiac support for patients, used by interventional cardiologists and cardiac care teams.

Companies that use Teleflex Medical Inc

Customer profile

Segments1 record

Ideal customer profiles2 records

Teleflex Medical Inc technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Teleflex Medical Inc partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • BIOTRONIKcoreStrategic or Co-development Partner · 1 January 2025Teleflex completed the acquisition of BIOTRONIK's Vascular Intervention Business in 2025. This strategic acquisition expands Teleflex's presence in the vascular intervention space, adding BIOTRONIK's portfolio of vascular devices to their existing product offerings.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Teleflex Medical Inc competitors and assessment

Company assessment

Broad incumbents

  • Stryker: Diversified medical device company with surgical instruments, emergency/critical care, and interventional products that overlap with Teleflex's surgical and emergency medicine portfolios.
  • Medtronic: Global medtech incumbent with overlapping portfolios in interventional cardiology, vascular, surgical, and urology. Comparable as a diversified medical device platform competing with Teleflex across multiple of the same hospital-facing specialties.
  • Becton Dickinson (BD): Large medtech incumbent with a strong vascular access, surgical instruments, and anesthesia delivery portfolio that directly overlaps with several of Teleflex's largest product areas.
  • Johnson & Johnson MedTech: Large medtech division with surgical, interventional, and vascular portfolios that directly overlap with Teleflex's surgical, interventional cardiology/radiology, and vascular access product areas.
  • Abbott: Major medtech incumbent with leading interventional cardiology, vascular, and structural heart franchises that compete with Teleflex's interventional cardiology/radiology and BIOTRONIK-acquired vascular intervention business.

Direct peers

  • CONMED: Smaller direct competitor focused on general surgery, interventional, and urology devices. Comparable in scale and product mix to Teleflex's surgical and urology franchises.
  • Integra LifeSciences: Mid-cap medtech peer with surgical instruments, neurosurgery, and specialty hospital products. Comparable as a diversified specialty medical device company selling into similar hospital channels as Teleflex.
  • Boston Scientific: Directly overlaps with Teleflex in interventional cardiology/radiology, vascular intervention, urology, and surgical devices. Boston Scientific's peripheral intervention and urology franchises compete head-to-head with Teleflex's interventional and Urolift portfolios.

Others

  • Integer Holdings: Contract manufacturer and supplier of medical device components and finished devices used across interventional and surgical categories. Comparable as an ecosystem participant supporting many of the same hospital-facing device categories as Teleflex.

Emerging players

  • Edwards Lifesciences: Focused cardiovascular device company whose structural heart and critical care products overlap with Teleflex's interventional cardiology portfolio and adjacent cardiac support devices such as the IABP Simplicity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Teleflex Medical Inc financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Teleflex Medical Inc leadership team

Management profile

Number of profiles

Profiles1 record

Teleflex Medical Inc subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Teleflex Medical Inc funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Teleflex Medical Inc M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teleflex Medical Inc

What does Teleflex Medical Inc do?

Teleflex manufactures and sells proprietary medical devices across multiple specialty areas, including anesthesia delivery and monitoring equipment, emergency medicine devices, interventional cardiology/radiology devices, surgical instruments, urology devices, and vascular access products. The company also offers the Urolift system for benign prostatic hyperplasia (BPH) treatment and supplies medical devices tailored for military and federal healthcare settings. Products are sold primarily to hospitals, surgical centers, emergency departments, and specialty medical practices worldwide.

Is Teleflex Medical Inc a public or private company?

Teleflex Medical Inc is a public company. It is classified as public and is currently operating.

When was Teleflex Medical Inc founded?

Teleflex Medical Inc was founded in 1943. It employs 5,001 to 10,000 people.

Where is Teleflex Medical Inc based?

Teleflex Medical Inc is headquartered in Morrisville, United States, in the North America region.

How does Teleflex Medical Inc make money?

One revenue line is on record: medical Device Sales.

Who are Teleflex Medical Inc's main competitors?

Broad incumbents on record are Stryker, Medtronic, Becton Dickinson (BD), Johnson & Johnson MedTech and Abbott. Direct peers are CONMED, Integra LifeSciences and Boston Scientific. Integer Holdings is listed as an others. Edwards Lifesciences is listed as an emerging player.

Does Teleflex Medical Inc have an API?

No public API is recorded for Teleflex Medical Inc.

What industry is Teleflex Medical Inc in?

Teleflex Medical Inc's product category is Medical Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Yahoo1 Small-Cap Stock with Competitive Advantages and 2 We Brush OffStockStory identified Celsius as a small-cap stock with competitive advantages while advising against investments in Xponential Fitness and Teleflex due to weak financial metrics and eroding returns. The analysis highlights Celsius's proprietary MetaPlus formula and natural ingredient focus as key strengths, whereas Xponential Fitness faces high debt risks and Teleflex struggles with below-standard growth. This report serves to isolate long-term investment winners from losers within the small-cap sector.The Globe and MailMinimally Invasive Fascial Closure Device Market Future Scope And Latest Trends Analysis ReportInsightAce Analytic released a market assessment report forecasting the global minimally invasive fascial closure device market to grow from US$ 331.2 Mn in 2023 to US$ 502.5 Mn by 2031, driven by rising obesity rates and demand for bariatric surgery. The report highlights key industry players including Teleflex Medical, Medtronic, and CooperSurgical, while noting regional growth in North America and Asia Pacific due to procedural trends and government initiatives.PR NewswireGlobal Breathing Filters & Bags Market 2015-2030: Key Trends, Revenues by Segment, Total Procedures, Units, ASPs, and Market Values by SegmentResearch and Markets has published a market analysis report covering the global Breathing Filters and Bags market from 2015 to 2030, with coverage across 39 countries and a focus on the COVID-19 pandemic's impact on this sector. The report provides granular data on procedures, units sold, average selling prices, and market values by segment, along with competitive dynamics, regulatory landscape, and reimbursement policies for each country. The market model includes company share/rank analysis for key players such as Teleflex Inc., Ambu A/S, Intersurgical Ltd., Draegerwerk AG & Co. KGaA, Smiths Medical, and Nolato AB.PR NewswireGlobal Benign Prostatic Hyperplasia Devices Market 2018-2022Technavio forecasts the global benign prostatic hyperplasia devices market to grow at a CAGR of 5.05% during the period 2018-2022, driven by increasing prevalence of the condition and a preference for minimally invasive surgical techniques. The report identifies key vendors operating in this space, including Boston Scientific, Olympus, and Teleflex, while noting high treatment costs as a primary challenge.PR NewswireExhibiting a steady 5.9% CAGR, the cardiac surgery instruments market is expected to rise to US$1,412.7 mn by 2022Transparency Market Research projects the global cardiac surgery instruments market to grow from US$1,061.4 million in 2017 to US$1,412.7 million by 2022, driven by a 5.9% compound annual growth rate. The report highlights North America as the dominant region and identifies key industry players including Becton, Dickinson and Company, Cardinal Health Inc., and Teleflex Incorporated.PR NewswireContinuous Peripheral Nerve Block Catheters Market: Non-stimulating Catheter Systems Will Continue to Gain TractionFuture Market Insights released a report projecting the global continuous peripheral nerve block catheters market to grow from US$ 372.8 Mn in 2015 to US$ 391.2 Mn in 2016, driven by increasing osteoarthritis prevalence and effective pain management applications. North America remains the leading market with a 42.4% revenue share, while B.Braun Melsungen AG holds the largest position among key industry players including Halyard Health and Teleflex Incorporated.